ABSTRACT
Specific cell-surface receptors mediate the endocytosis ofthe major yolk components, very low density lipoprotein (VLDL) (1) and vitellogenin (VTG) (2) by growing oocytes of the laying hen. By ligand blotting, we have identified (1) the chicken oocyte VLDL receptor as a protein with an apparent molecular mass of 95 kDa, as determined by SDS/PAGE in the absence of sulfhydryl-reducing agents (1) . With the same biochemical tool as used for the identification of the VLDL receptor, namely ligand blotting, a protein to which we assigned an apparent molecular mass of 96 kDa under identical experimental conditions has been shown to be the receptor for VTG on the chicken oocyte plasma membrane (2) . Interestingly, a polyclonal rabbit IgG fraction raised against the pure bovine low density lipoprotein (LDL) receptor recognized the VLDL receptor (1) and immunoprecipitated VTG-binding activity from chicken oocyte membrane extracts (2) . Furthermore, receptor-binding of VTG and VLDL was abolished by reductive methylation of lysine residues in both ligands, and exposure of oocyte membrane extracts to sulfhydryl-reducing agents abolished the ability to bind the two ligands (1, 2) .
These findings of essentially identical apparent molecular masses, immunological properties, and biochemical properties suggested to us a close relationship, if not identity of the chicken oocyte receptors for VLDL and VTG. In preliminary competitive filtration binding assays (unpublished observations), we observed that high concentrations of unlabeled VTG and VLDL competed with the binding of both '251-labeled VTG and VLDL to chicken oocyte membrane extracts, further suggesting the presence of one bifunctional receptor. In the light of the pivotal role of receptor-mediated endocytosis of yolk proteins in the reproductive effort of the hen, coupled to the inability of the oocyte to synthesize yolk proteins (3) , it seemed reasonable to us that one and the same chicken oocyte plasma membrane receptor would be responsible for the import ofthe major yolk lipoproteins, VLDL and VTG. However, it is entirely possible that the receptors are different molecules, since direct evidence for their identity has not been provided.
In the studies reported here, we took advantage of our biochemical and immunological tools for the identification and characterization of chicken oocyte receptors, as well as of a powerful genetic model for addressing this question, namely the mutant "restricted-ovulator" (R/O) strain of chickens (4, 5). As we have reported (4) 
MATERIALS AND METHODS
Materials, Animals, and Diets. We obtained CNBractivated Sepharose 4B (catalogue no. 17-04300-01) and Sephadex G-200, superfine, from Pharmacia. All other materials were from reported sources (1, 2) . White Leghorn hens and roosters were purchased from the Department of Animal Science, The University of Alberta, and maintained as described (1, 2). Oocytes were also collected during slaughter by permission of Lilydale Poultry Sales (Edmonton, AB). R/O hens were selected from hatchlings kindly provided by J. James Bitgood (Poultry Science Department, University of Wisconsin, Madison) and maintained as described (4) .
Preparation of Antibodies. Polyclonal rabbit antibodies against the bovine LDL receptor (1) and the chicken oocyte VTG receptor (2) were raised. Polyclonal antibodies against the VLDL-Sepharose affinity-purified receptor were obtained by immunization of adult female New Zealand rabbits as described (4) .
Lipoprotein Isolation and Radioiodination. Lipoprotein fractions (1) membrane Triton X-100 extracts (800 ,g of protein), were mixed with 2 vol of buffer A and applied to and recycled over the affinity columns for a total of 2 hr. Columns were then washed with 50 bed-volumes of a buffer containing 50 mM Tris-HCl (pH 7.8), 4 mM CaCl2, and 0.1% Triton X-100 (buffer B) and material was eluted with 2 bed-volumes of a solution of 0.5 M NH40H. The eluted fractions were immediately dialyzed against a buffer containing 25 mM Tris HCl (pH 7.8), 50 mM NaCl, and 2 mM CaCl2 and subsequently concentrated to approximately one-fifth of the initial volume by using Amicon Centricon-30 microconcentrators. Concentrated material, hereafter referred to as the VTG affinity fraction, was immediately applied to SDS/polyacrylamide gels for electrophoresis, transfer to nitrocellulose, and ligand blotting as described in the figure legends. Control experiments were performed exactly as described above except that bovine serum albumin was covalently coupled to CNBractivated Sepharose 4B at 30 mg of protein per g of dry gel. Affinity Chromatography: VLDL-Sepharose 4B.. Yolk VLDL, prepared as described (14) was coupled to CNBractivated Sepharose 4B according to the manufacturer's instructions (13) , by using 35 mg of yolk VLDL per g of dry gel. The yolk VLDL-Sepharose 4B was stored at 4°C in a buffer containing 50 mM Tris HCl (pH 8.0), 2 mM CaC12, and 0.02% NaN3. Affinity chromatography was conducted at 4°C using a 1.5 x 10 cm bed, essentially as described for VTGSepharose 4B. The ammonia-eluted fractions were lyophilized, dissolved in buffer containing 50 mM Tris HCl (pH 8.0), 2 mM CaCl2, 200 mM NaCl, and 10 mM 3-[(3-cholamidopropyl)dimethyl-ammonia]-1-propane-sulfonate (CHAPS) and quickly frozen in liquid nitrogen. Upon storage at -700C, these samples were stable for at least 3 months.
RESULTS AND DISCUSSION
When chicken oocyte membrane extracts were analyzed by ligand blotting with radiolabeled VTG and VLDL, protein bands with identical electrophoretic mobility were visualized with both ligands (Fig. 1 above the 200-kDa standard, also observed with both ligands. The intensity of this band varied widely in different preparations of oocyte membrane extracts and is likely related to di-or oligomeric forms of the receptor such as described for the mammalian LDL receptor (15) .
To further investigate the properties of the 95-kDa protein(s), oocyte membrane detergent extracts were subjected to affinity chromatography on a column of Sepharoseimmobilized yolk VLDL and then to gel-exclusion chromatography on Sephadex G-200 in buffer containing 30 ,ug/ml (110 cpm/ng); B and F, for competition, VTG at 1.8 mg/ml was added; C and E, VLDL at 1.8 mg/ml was added. The autoradiograph was exposed for 24 hr (A-C) or 
hr (D-F).
These findings support our proposal that the 95-kDa band constitutes a single polypeptide with dual binding capacity.
To further investigate this possibility, we pursued our previous observations with polyclonal rabbit IgG fractions raised against the bovine LDL receptor (1, 4, 16) and against a protein band, shown by ligand blotting to bind VTG, that had been electroeluted from an SDS/polyacrylamide gel (2).
1251-VLDL
Here, we have obtained another polyclonal rabbit IgG fraction that was raised against the single protein obtained by VLDL-Sepharose affinity purification ( Fig. 2A) . In ligand blots, this IgG fraction inhibited in identical concentrationdependent fashion the binding of 125I-labeled VTG and VLDL to the 95-kDa band (Fig. 3) Fig. 4 , VLDL and VTG bound to a 95-kDa band in the crude oocyte extract, as expected ( lanes 1 and 4) ; the unbound fraction was devoid of binding capacity for both ligands (lanes 2 and 5); and the eluted fraction bound both ligands (lanes 3 and 6). We do believe that the VTG receptor and the VLDL receptor (if it were different from the former) were bound in specific fashion to the VTG-Sepharose, because Sepharose containing covalently linked bovine serum albumin did not retain the VLDLor the VTG-binding activity in nonspecific fashion (lanes [7] [8] [9] [10] [11] [12] . Thus, the 95-kDa protein binds both VTG and VLDL.
In addition to the strong biochemical evidence for identity of the VLDL receptor with the VTG receptor, we obtained support from a genetic model. We have shown (4) that the nonlaying R/O hen's phenotype is due to the lack of functional oocyte receptors for VLDL (4) . Since breeding studies have established that the R/O strain carries a single gene defect (6, 7) and since this mutation results in abolition of VLDL receptor activity or gene expression (4), we tested whether the binding of VTG to R/O ovarian membranes was equally affected. As shown in Fig. 5, detergent 1'-7' ). The positions of migration of molecular mass standards are indicated.
The autoradiograph was exposed for 16 hr. residues). Highly significant comparison scores (P < [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] were observed for residues of apoB-100 versus residues 24-605 of chicken VTG. Such similarities might indicate that apoB and VTG could bind through common structural elements, possibly to complementary site(s) on the receptor. Unfortunately, the sequence of only 433 amino acid residues at the C terminus of chicken apoB (which has approximately the same size as human apoB) is known (20) , and thus, no direct comparison between chicken VTG (1850 residues) and chicken apoB in the N-terminal region is possible at present. Nevertheless, it is conceivable that a sufficiently similar domain(s) exists on the two ligands through which they might bind to a common site on the receptor.
However, we do not need to postulate that binding of the two ligands occurs to the same site on the receptor. Namely, in reference to the above, the domain on human apoB that most likely mediates binding to the human LDL receptor is believed to be located in the C-terminal one-third of the protein (21, 22) , outside the region of similarity between apoB and VTG identified by Baker (18) . Also, in addition to the ligand-blotting experiments (Figs. 1 and 2 (24) . The apoB/E binding domain of the mammalian LDL receptor is located at its N terminus and consists of seven homologous cysteine-rich -40-residue repeats (25, 26) . Site-directed mutagenetic studies (27) suggested that these repeats are functionally nonequivalent: while the N-terminally located first repeat does not appear to have a role in ligand binding, repeats 2, 3, 6, and 7 are required for maximal binding of LDL (through apoB), and repeat 5 is essential for binding off-VLDL (through apoE; cf. refs. 28 and 29). Thus, apoB and apoE, which compete with each other for receptor binding, interact with the same general domain but different substructures thereof. We have shown (16) that the chicken oocyte 95-kDa protein binds apoB as well as p-VLDL, and thus most likely apoE (28) . Since chickens do not synthesize apoE (30) and mammals do not synthesize VTG, it is tempting to speculate that VTG may represent a counterpart to apoE that has evolved in oviparous species. In this context, it will be of interest to test whether VTG is recognized by LDL receptors of mammalian species; to our knowledge no such studies have been reported to date.
Finally, as Fig. 2A shows, this receptor is a major protein of the oocyte plasma membrane and not a minor membrane component such as the mammalian LDL receptor (31) . From a teleological as well as economical point of view, it would be advantageous to the yolk-accumulating oocytes of oviparous species to minimize the complexity ofthe machinery required for their growth-i.e., the reproductive effort of the female. Hence, since VLDL and VTG combined contribute by far the largest portion of yolk, a receptor system appears to have evolved that mediates the uptake of two apparently diverse ligands into oocytes.
